AVR stock news · Anteris Technologies
Get alerts for AVR
Follow Anteris Technologies (AVR) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for AVRFree on the App Store and Google Play, or on the web.
Anteris Technologies Reports Positive 30-Day Outcomes for Medium-Size DurAVR THV in EMBARK Study
Good for AVRAnteris reported results for 22 patients: valve opening rose from 0.8 to 2.64 cm², with a 6.17 mmHg average pressure gradient. This supports AVR, but follow-up lasted 30 days.
Anteris Technologies Global Corp. has signed an important deal to keep working with Harvey Industries Group Pty Ltd.
NeutralAnteris extended its supplier agreement to Dec 31, 2026; this administrative step is routine and does not change the company's outlook.
Anteris Technologies Global Corp. is changing some of its leaders and giving them new pay packages.
NeutralAnteris approved contingent executive options and PSUs requiring shareholder approval; I read this as neutral because outcomes are conditional and balance alignment with dilution risk.